Less Ads, More Data, More Tools Register for FREE

Sector movers: Defensives knocking at technical resistance's door

Sat, 20th Aug 2022 17:01

(Sharecast News) - Interest rate sensitive segments of the FTSE 3500 dragged the index lower at the end of the week, as investors digested a flurry of Fed speakers overnight whose overarching message appeared to be that interest rates would remain higher for longer, although there were slight variations as to just how high.

Worth keeping in mind was the significant impact that rates in the US had on UK financial markets.

Hence the declines seen Household Goods & Home Construction or REITS or real estate investment services.

Nevertheless, a 0.85% drop in Sterling's value against the Greenback to 1.1829 meant that the FSTE 350 ended the day only marginally lower, flattish even.

Going the other way, defensives including Big Pharma and Tobacco stocks pushed higher, alongside Big Oil.

Worth noting perhaps, AstraZeneca stock notched up a fresh record high with its US-traded ADRs not far behind.

In parallel, British American Tobacco shares were knocking at the door of near-term technical resistance around the 3,551p area. as were those of oil giant BP.

Top performing sectors so far today

Pharmaceuticals & Biotechnology 20,728.53 +1.69%

Personal Care, Drug and Grocery Stores 4,277.11 +1.43%

Beverages 30,125.14 +1.19%

Oil, Gas and Coal 7,823.48 +1.11%

Tobacco 36,583.22 +0.50%

Bottom performing sectors so far today

Automobiles & Parts 1,770.75 -4.91%

Travel & Leisure 6,331.06 -2.13%

Household Goods & Home Construction 11,891.02 -2.04%

Real Estate Investment Trusts 2,817.64 -2.02%

Real Estate Investment & Services 2,590.41 -1.95%

Related Shares

More News
Today 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

17 Jun 2024 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Ba...

17 Jun 2024 07:23

IN BRIEF: AstraZeneca gets positive cancer test results for Calquence

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Reports promising test results for one of its cancer therapies. The Echo phase III t...

17 Jun 2024 07:15

AstraZeneca's Imfinzi gets US approval for endometrial cancer patients

(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.